0.45 +0.00 (0.00%)
SNSS
Stock Details
Last Trade:0.45 Change:+0.00 (0.00%) Prev Close:0.45 Open: 0.63 Days Range:0.38 – 0.63 52 Week Range: 0.18 - 2.24 Volume:21837 P/E: N/AEPS:-1.24
View AllRecent Alerts 12/02/08
Recent Alert on 11/04/08 at 8:55am
Sunesis Pharmaceuticals (SNSS) Reports Q3 Loss of 21c
Sunesis Pharmaceuticals (SNSS) Reports Q3 Loss of 21c
Sunesis Pharmaceuticals (Nasdaq: SNSS) reports Q3 loss of $0.21, versus the analyst estimate of ($0.42). Revenue for the quarter was $510.42 thousand, versus the consensus of $1.17 million.
Recent Alert on 10/21/08 at 11:40am
Susquehanna Initiates Coverage on Sunesis Pharmaceuticals (SNSS) with a Positive
Susquehanna Initiates Coverage on Sunesis Pharmaceuticals (SNSS) with a Positive
View AllRecent Press Releases
Press Release on 12/01/08 at 8:00am
Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 08/12/08 at 7:23am
Top Pre-Market Analyst Upgrades (ALK, AMR, AAPL, CAL, DAL, DELL, JPM, LDK, PENN, SCR, SNSS, LCC)
Top Pre-Market Analyst Upgrades (ALK, AMR, AAPL, CAL, DAL, DELL, JPM, LDK, PENN, SCR, SNSS, LCC)